<DOC>
	<DOCNO>NCT02466919</DOCNO>
	<brief_summary>The study aim evaluate H. pylori eradication rate diabetic patient use novel 10-day levofloxacin-based concomitant therapy compare conventional 10-day sequential therapy .</brief_summary>
	<brief_title>Study Levofloxacin-based Concomitant Therapy H. Pylori Eradication Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Diabetic patient Helicobacter pylori infection Pregnancy physically poor performance status Patients contraindication upper endoscopy Severe coagulopathy endoscopic biopsy Chronic kidney disease ( eGFR &lt; 50 ) end stage renal disease Known allergy interventional drug Previous eradication failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Helicobacter pylorus</keyword>
</DOC>